mAb (C12); Mouse anti Human FABP4 Antibody; WB, IHC; Unconjugated
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab102606-10μl | 10μl | In stock | $59.90 | |
| Ab102606-20μl | 20μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $89.90 | |
| Ab102606-50μl | 50μl | In stock | $179.90 | |
| Ab102606-100μl | 100μl | In stock | $279.90 | |
| Ab102606-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,299.90 |
mAb (C12); Mouse anti Human FABP4 Antibody; WB, IHC; Unconjugated
| Product Name | FABP4 Mouse mAb - Primary antibody, specific to FABP4, Mouse IgG1 |
|---|---|
| Synonyms | 3T3-L1 lipid-binding protein antibody; 422/aP2 antibody; A-FABP antibody; adipocyte antibody; Adipocyte lipid binding protein antibody; Adipocyte lipid-binding protein antibody; Adipocyte protein AP2 antibody; Adipocyte-type fatty acid-binding protein ant |
| Specifications & Purity | ExactAb™, Validated, Carrier Free, Azide Free, High performance, Lot by Lot |
| Host species | Mouse |
| Specificity | FABP4 |
| Immunogen | Recombinant FABP4 expressed in E.coli (AA 2-132) |
| Positive Control | WB: Mouse heart, Mouse skeletal muscle tissue lysates and HUVEC cell lysate. IHC: Human and Porcine cardiac muscle tissues. |
| Conjugation | Unconjugated |
| Grade | Azide Free, Carrier Free, ExactAb™, High performance, Validated |
| Product Description | Mouse anti Human FABP4 Antibody, Monoclonal (C12), could be used for WB, IHC and so on. Application WB: 0.01-2 µg/mL IHC: 5-20 μg/mL Protein Function Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus. |
| Isotype | Mouse IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 150 kDa |
| Purification Method | Protein A + Protein G purified |
| Form | Liquid |
| Concentration | Lot by Lot |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4℃ short term (1-2 weeks). Store at -20℃ long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
FABP4 Mouse mAb (Ab102606) - Western Blot
All lanes: FABP4 Mouse mAb (Ab102606) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138040) at 1/40000 dilution
Predicted band size: 15 kDa
Observed band size: 14 kDa
Exposure time: 0.9 s
FABP4 Mouse mAb (Ab102606) - Western Blot
All lanes: FABP4 Mouse mAb (Ab102606) at 1/2000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Mouse IgG H&L (HRP) (Ab138040) at 1/20000 dilution
Predicted band size: 15 kDa
Observed band size: 14 kDa
Exposure time: 159.3 s
FABP4 Mouse mAb (Ab102606) - IHC
DAB staining on IHC
Sample: Porcine Cardiac Muscle Tissue
Primary Ab: 10 µg /mL FABP4 Mouse mAb (Ab102606)
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.
FABP4 Mouse mAb (Ab102606) - IHC
DAB staining on IHC
Sample: Human Cardiac Muscle Tissue
Primary Ab: 10 µg/mL FABP4 Mouse mAb (Ab102606)
Control: Used PBS instead of primary antibody
Second Ab: 2 µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Application | Dilution info |
|---|---|
| IHC | 5-20 µg/mL |
| WB |
0.01-2 µg/mL
|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0102397 | Certificate of Analysis | Jan 10, 2024 | Ab102606 |
| ZJ24F0102396 | Certificate of Analysis | Jan 10, 2024 | Ab102606 |
| ZJ24F0102395 | Certificate of Analysis | Jan 10, 2024 | Ab102606 |
| 1. Hertzel AV, Hellberg K, Reynolds JM, Kruse AC, Juhlmann BE, Smith AJ, Sanders MA, Ohlendorf DH, Suttles J, Bernlohr DA. (2009) Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.. J Med Chem, 52 (19): (6024-31). [PMID:19754198] |
| 2. Liu X, Huang X, Lin W, Wang D, Diao Y, Li H, Hui X, Wang Y, Xu A, Wu D et al.. (2011) New aromatic substituted pyrazoles as selective inhibitors of human adipocyte fatty acid-binding protein.. Bioorg Med Chem Lett, 21 (10): (2949-52). [PMID:21481589] |
| 3. Oddi S, Scipioni L, Totaro A, Angelucci C, Dufrusine B, Sabatucci A, Tortolani D, Coletta I, Alisi MA, Polenzani L et al.. (2019) The anti-inflammatory agent bindarit acts as a modulator of fatty acid-binding protein 4 in human monocytic cells.. Sci Rep, 9 (1): (15155). [PMID:31641194] |
| 4. Haiyan Cai,Guirui Yan,Xiaodong Zhang,Olena Gorbenko,Heyao Wang,Weiliang Zhu. (2010-05-18) Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.. Bioorganic & medicinal chemistry letters, 20 ((12)): (3675-3679). [PMID:20471252] |
| 5. Lehmann F, Haile S, Axen E, Medina C, Uppenberg J, Svensson S, Lundbäck T, Rondahl L, Barf T.. (2004) Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target.. Bioorg Med Chem Lett, 14 (17): (4445-4448). [PMID:15357969] |
| 6. Barf T, Lehmann F, Hammer K, Haile S, Axen E, Medina C, Uppenberg J, Svensson S, Rondahl L, Lundbäck T.. (2009) N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.. Bioorg Med Chem Lett, 19 (6): (1745-1748). [PMID:19217286] |
| 7. Cai H, Liu Q, Gao D, Wang T, Chen T, Yan G, Chen K, Xu Y, Wang H, Li Y, Zhu W.. (2015) Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.. Eur J Med Chem, 90 (241-250). [PMID:25461324] |
| 8. Zhou Y, Nie T, Zhang Y, Song M, Li K, Ding M, Ding K, Wu D, Xu Y.. (2016) The discovery of novel and selective fatty acid binding protein 4 inhibitors by virtual screening and biological evaluation.. Bioorg Med Chem, 24 (18): (4310-4317). [PMID:27460668] |
| 9. Kühne H, Obst-Sander U, Kuhn B, Conte A, Ceccarelli SM, Neidhart W, Rudolph MG, Ottaviani G, Gasser R, So SS, Li S, Zhang X, Gao L, Myers M.. (2016) Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors.. Bioorg Med Chem Lett, 26 (20): (5092-5097). [PMID:27658368] |
| 10. Gao DD, Dou HX, Su HX, Zhang MM, Wang T, Liu QF, Cai HY, Ding HP, Yang Z, Zhu WL, Xu YC, Wang HY, Li YX.. (2018) From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4.. Eur J Med Chem, 154 (44-59). [PMID:29775936] |
| 11. Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Wang L, Bogdan DM, Falcone J, Smietalo N, Zhou Y, Ralph B, Hsu HC, Li H, Rizzo RC, Deutsch DG, Kaczocha M, Ojima I.. (2018) SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.. Eur J Med Chem, 154 (233-252). [PMID:29803996] |
| 12. He Y, Dou H, Gao D, Wang T, Zhang M, Wang H, Li Y.. (2019) Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.. Bioorg Med Chem, 27 (19): (115015-115015). [PMID:31420256] |
| 13. Oukoloff K, Lucero B, Francisco KR, Brunden KR, Ballatore C.. (2019) 1,2,4-Triazolo[1,5-a]pyrimidines in drug design.. Eur J Med Chem, 165 (332-346). [PMID:30703745] |
| 14. Baxa, C A CA and 7 more authors.. (1989) Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA.. Biochemistry, (31): [PMID:2481498] |
| 15. Sjöblom, Tobias T and 28 more authors.. (2006) The consensus coding sequences of human breast and colorectal cancers.. Science (New York, N.Y.), (13): [PMID:16959974] |
| 16. Bienvenut, Willy V WV and 6 more authors.. (2012) Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-α-acetylation features.. Molecular & cellular proteomics : MCP, [PMID:22223895] |
| 17. Rosenow, Anja A and 6 more authors.. (2012) Resveratrol-induced changes of the human adipocyte secretion profile.. Journal of proteome research, (7): [PMID:22905912] |
